Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
144,200,694
-
Share change
-
+3,655,861
-
Total reported value
-
$1,395,740,531
-
Put/Call ratio
-
51%
-
Price per share
-
$9.68
-
Number of holders
-
219
-
Value change
-
+$40,540,498
-
Number of buys
-
117
-
Number of sells
-
99
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q2 2014
As of 30 Jun 2014,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
219 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
144,200,694 shares.
The largest 10 holders included
Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, SCHRODER INVESTMENT MANAGEMENT GROUP, ACADIAN ASSET MANAGEMENT LLC, Advisors Asset Management, Inc., BlackRock Institutional Trust Company, N.A., WELLS FARGO & COMPANY/MN, and State Street Corp.
This page lists
219
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.